2020
DOI: 10.1097/md.0000000000020369
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of prostaglandina E1 for the treatment of patients with thrombo-occlusive vasculitis

Abstract: Background: This study aims to explore the efficacy and safety of prostaglandina E1 (PE1) for the treatment of patients with thrombo-occlusive vasculitis (TOV). Methods: Electronic databases (Cochrane Library, PUBMED, EMBASE, Web of Science, Scopus, the Allied and Complementary Medicine Database, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure) will be sought from onset to the March 1, 2020 without language and public… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
0
0
Order By: Relevance
“…In various studies, several effects of medical interest have been demonstrated, such as vasodilation, improvement in cutaneous oxygenation, fibrinolytic activity, antiplatelet activity, and even a decrease in reperfusion injury. [25][26][27][28][29] The use of epoprostenol has been studied in conjunction with vasodilators and antiplatelets, with significant improvement in temperature and distal flow, however, beneficial effects were observed only after 1 week. 30 The use of intravenous prostanoids such as Iloprost with healing of ischemic ulcers after infusion for 6 hours for 5 days has also been proposed.…”
Section: Prostaglandinsmentioning
confidence: 99%
“…In various studies, several effects of medical interest have been demonstrated, such as vasodilation, improvement in cutaneous oxygenation, fibrinolytic activity, antiplatelet activity, and even a decrease in reperfusion injury. [25][26][27][28][29] The use of epoprostenol has been studied in conjunction with vasodilators and antiplatelets, with significant improvement in temperature and distal flow, however, beneficial effects were observed only after 1 week. 30 The use of intravenous prostanoids such as Iloprost with healing of ischemic ulcers after infusion for 6 hours for 5 days has also been proposed.…”
Section: Prostaglandinsmentioning
confidence: 99%